Page 50 - Success Story
P. 50
Treating Hyperuricemia
Patients undergoing anti-cancer therapy are at a
higher risk of developing elevated plasma levels of uric
acid. This can give rise to metabolic disorders and life
threatening complications such as hyperuricemia.
The drugs to lower uric acid levels are highly indispensable. Urate RASBELON
Oxidase enzyme is considered as the most promising therapeutic
candidate for reducing the uric acid levels.
50
